Form 4: Goosehead Insurance Director James Reid Granted Stock Options
SEC Form 4 Filing
Director James Reid of Goosehead Insurance, Inc. was granted stock options exercisable for 6,586 shares of Class A Common Stock on May 6, 2025, according to a recent SEC filing.
Summary
- James Reid, a director at Goosehead Insurance, Inc., was granted stock options on May 6, 2025.
- The options are exercisable for 6,586 shares of Class A Common Stock at a price of $102.70.
- The options vest in 12 equal quarterly installments over three years, starting from the grant date, subject to continued service.
- Full vesting occurs upon a change in control of the Issuer.
- The options expire on May 6, 2035.
- John O'Connor, as Attorney-in-Fact for James Reid, signed the filing on May 8, 2025.
- A power of attorney document was included, granting John O'Connor and Mark E. Jones, Jr. the authority to execute Forms 3, 4, and 5 on behalf of James Reid.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices. The grant of options is generally viewed as a positive incentive for management.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders.
- The vesting schedule incentivizes continued service and commitment to the company.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
Stock option grants are a common form of executive compensation in the insurance industry, aligning management's interests with shareholder value creation.
Comparison to Industry Standards
- Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, including those in the insurance sector.
- Companies like Progressive, Allstate, and Travelers also utilize stock options as part of their executive compensation plans.
- The vesting schedule and exercise price are generally determined based on industry benchmarks and company-specific performance metrics.
Stakeholder Impact
- The stock option grant could potentially increase shareholder value if the director's performance leads to improved company performance.
- Employees may view the grant as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| May 7, 2024 | Date of execution for the Power of Attorney document. |
| May 6, 2025 | Date of the stock option grant. |
| May 8, 2025 | Date of the SEC filing. |
| May 6, 2035 | Expiration date of the stock options. |
Keywords
stock options, Goosehead Insurance, director, James Reid, SEC Form 4, beneficial ownership, vesting, power of attorney
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.